Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
| Autor: | Al Baghdadi, Tareq, Rothe, Michael, Mangat, Pam K., Garrett-Mayer, Elizabeth, Yost, Kathleen J, Chiu, Vi Kien, Duvivier, Herbert Leon, McKean, Meredith, Rueter, Jens, Taylor, Mark A., Grantham, Gina N., Gregory, Abby, Hinshaw, Dominique C., Halabi, Susan, Schilsky, Richard L. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p308-308, 185p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|